<DOC>
	<DOCNO>NCT01259024</DOCNO>
	<brief_summary>This study involve combine use FDA approve device , LC Bead FDA approve drug , Doxorubicin treatment primary hepatocellular carcinoma ( HCC ) . The current indication LC Bead embolization hypervascular tumor arteriovenous malformation . The study design establish drug elute bead effective less toxic standard chemoembolization treatment .</brief_summary>
	<brief_title>The LC Bead Trial ; Transarterial Chemoembolization Hepatocellular Carcinoma ( HCC ) With Drug-eluting Bead</brief_title>
	<detailed_description>Patients give IV fluid premedication 500 mg metronidazole , 10 mg dexamethasone , 8 mg ondansetron prevent infection , limit pain nausea . The femoral artery access catheter advance superior mesenteric artery . Positioning catheter confirm injection radiographic contrast material . Superior mesenteric angiography perform image obtain portal venous phase confirm patency flow direction portal vein determine presence aberrant supply right lobe liver superior mesenteric artery . The catheter advance celiac artery . Celiac angiography perform determine remainder hepatic arterial anatomy . Selection tumor bearing artery perform microcatheter advanced catheter celiac artery origin . Selection guide fluoroscopy lobar level peripherally case . Once feeding vessel select confirm contrast injection , physician initiate embolization LC Beads . Up two vial LC Beads administer . One 2 mL vial 300-500 500-700 um LC Beads 37.5 mg/mL doxorubicin prepare . The LC Beads mixed radiographic contrast ensure fluoroscopic visibility injection . Under careful fluoroscopic control , vial 300-500 um vial infuse , follow vial 500-700 um LC Beads . If artery reach stasis prior administration vial , residual volume LC Beads note surgical report form . If administration DEB , residual antegrade flow feed artery , treat bland embolization similar chemoembolization . After confirm artery appropriately treat , catheter guidewires remove femoral artery hemostasis obtain .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<criteria>Age &gt; 18 Patent main portal vein hepatopetal flow Bilirubin le equal 2.5 mg/dl , albumin &gt; 2.8g/dl , alkaline phosphatase &lt; 630IU/L , AST &lt; 235IU/L , ALT &lt; 265IU/L , INR &lt; 2.0 , PTT &lt; 40sec. , absolute neutrophil count &gt; 1K/cumm , platelet count &gt; 100K/cumm No encephalopathy No previous biliary ductal intervention Child A status Confirmation Hepatocellular Carcinoma ( biopsy radiological exam ) Unresectable HCC ineligible possible curative therapy Normal ECG QT &lt; 480 msec within previous 2 month Normal MUGA scan within previous 2 month Measureable disease per Response Evaluation Criteria Solid Tumors ( RECIST ) Subject competent willing provide write informed consent order participate study Thrombosis hepatofugal flow main portal vein ; presence large shunt operator 's opinion precludes embolization Replacement great 50 % liver parenchyma tumor Bilirubin great equal 2.6 mg/dl ECOG performance status 2 great Previous liver direct therapy Previous biliary intervention ( exclude cholecystectomy ) Allergy iodinate contrast use angiography Elevated creatinine great equal 1.8 mg/dl Women pregnant nursing Patients follow contraindicate : 1 ) use doxorubicin , 2 ) MRI CT scan , 3 ) Hepatic embolization procedure Patients active bacterial fungal infection deem clinically significant investigator Patients cardiac disease , include congestive heart failure , recent myocardial infarction , uncontrolled arrhythmia NonEnglish speaking patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>chemoembolization</keyword>
	<keyword>transarterial chemoembolization</keyword>
	<keyword>liver cancer</keyword>
	<keyword>doxorubicin</keyword>
	<keyword>drug-eluting bead</keyword>
	<keyword>LC Bead</keyword>
</DOC>